- Home
- RMAX vs ATAI Comparison
RMAX vs ATAI Comparison
Compare RMAX & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMAX
- ATAI
- Stock Information
- Founded
- RMAX 1973
- ATAI 2018
- Country
- RMAX United States
- ATAI Germany
- Employees
- RMAX N/A
- ATAI N/A
- Industry
- RMAX Real Estate
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- RMAX Finance
- ATAI Health Care
- Exchange
- RMAX Nasdaq
- ATAI Nasdaq
- Market Cap
- RMAX 215.3M
- ATAI 214.8M
- IPO Year
- RMAX 2013
- ATAI 2021
- Fundamental
- Price
- RMAX $13.25
- ATAI $1.61
- Analyst Decision
- RMAX Hold
- ATAI Strong Buy
- Analyst Count
- RMAX 5
- ATAI 4
- Target Price
- RMAX $10.38
- ATAI $9.00
- AVG Volume (30 Days)
- RMAX 273.7K
- ATAI 2.3M
- Earning Date
- RMAX 10-31-2024
- ATAI 11-13-2024
- Dividend Yield
- RMAX N/A
- ATAI N/A
- EPS Growth
- RMAX N/A
- ATAI N/A
- EPS
- RMAX N/A
- ATAI N/A
- Revenue
- RMAX $311,818,000.00
- ATAI $331,000.00
- Revenue This Year
- RMAX N/A
- ATAI $44.72
- Revenue Next Year
- RMAX $0.73
- ATAI N/A
- P/E Ratio
- RMAX N/A
- ATAI N/A
- Revenue Growth
- RMAX N/A
- ATAI N/A
- 52 Week Low
- RMAX $6.94
- ATAI $1.03
- 52 Week High
- RMAX $13.70
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- RMAX 63.58
- ATAI 61.07
- Support Level
- RMAX $10.85
- ATAI $1.53
- Resistance Level
- RMAX $13.31
- ATAI $1.95
- Average True Range (ATR)
- RMAX 0.62
- ATAI 0.22
- MACD
- RMAX 0.06
- ATAI 0.03
- Stochastic Oscillator
- RMAX 94.71
- ATAI 62.22
About RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.